InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $35.60 million. The enterprise value is -$2.86 million.
| Market Cap | 35.60M |
| Enterprise Value | -2.86M |
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 46.84 million shares outstanding. The number of shares has increased by 58.68% in one year.
| Current Share Class | 46.84M |
| Shares Outstanding | 46.84M |
| Shares Change (YoY) | +58.68% |
| Shares Change (QoQ) | +1.74% |
| Owned by Insiders (%) | 16.47% |
| Owned by Institutions (%) | 22.24% |
| Float | 26.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.28 |
| Forward PS | 3.09 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.15, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.15 |
| Quick Ratio | 4.70 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -142.60% and return on invested capital (ROIC) is -84.20%.
| Return on Equity (ROE) | -142.60% |
| Return on Assets (ROA) | -68.49% |
| Return on Invested Capital (ROIC) | -84.20% |
| Return on Capital Employed (ROCE) | -110.85% |
| Weighted Average Cost of Capital (WACC) | 7.65% |
| Revenue Per Employee | $85,417 |
| Profits Per Employee | -$404,008 |
| Employee Count | 127 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 2.66 |
Taxes
In the past 12 months, InspireMD has paid $63,000 in taxes.
| Income Tax | 63,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.24% in the last 52 weeks. The beta is 0.74, so InspireMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -67.24% |
| 50-Day Moving Average | 1.11 |
| 200-Day Moving Average | 1.76 |
| Relative Strength Index (RSI) | 29.45 |
| Average Volume (20 Days) | 190,237 |
Short Selling Information
The latest short interest is 18,004, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 18,004 |
| Short Previous Month | 35,122 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.07% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, InspireMD had revenue of $10.85 million and -$51.31 million in losses. Loss per share was -$0.71.
| Revenue | 10.85M |
| Gross Profit | 3.04M |
| Operating Income | -52.13M |
| Pretax Income | -51.25M |
| Net Income | -51.31M |
| EBITDA | -51.61M |
| EBIT | -52.13M |
| Loss Per Share | -$0.71 |
Balance Sheet
The company has $41.57 million in cash and $3.11 million in debt, with a net cash position of $38.46 million or $0.82 per share.
| Cash & Cash Equivalents | 41.57M |
| Total Debt | 3.11M |
| Net Cash | 38.46M |
| Net Cash Per Share | $0.82 |
| Equity (Book Value) | 43.62M |
| Book Value Per Share | 0.93 |
| Working Capital | 39.15M |
Cash Flow
In the last 12 months, operating cash flow was -$38.65 million and capital expenditures -$1.50 million, giving a free cash flow of -$40.15 million.
| Operating Cash Flow | -38.65M |
| Capital Expenditures | -1.50M |
| Depreciation & Amortization | 527,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -40.15M |
| FCF Per Share | -$0.86 |
Margins
| Gross Margin | 28.06% |
| Operating Margin | -480.57% |
| Pretax Margin | -472.40% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.68% |
| Shareholder Yield | -58.68% |
| Earnings Yield | -144.14% |
| FCF Yield | -112.77% |
Analyst Forecast
The average price target for InspireMD is $3.67, which is 382.90% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.67 |
| Price Target Difference | 382.90% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 235.08% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
InspireMD has an Altman Z-Score of -6.01 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.01 |
| Piotroski F-Score | 4 |